Mavacamten is approved for treating obstructive hypertrophic cardiomyopathy, with real-world data supporting its safety and efficacy. The REMS program is crucial for monitoring mavacamten's safety ...

A new Medicare pilot program will require prior authorization for certain medical procedures, using AI to approve or deny coverage A new program from the Centers for Medicare and Medicaid Services ...

SOURCES Data on UIP reimbursement amounts are from Health Resources and Services Administration claims reimbursement data, containing vaccine administration reimbursement amounts issued by the UIP ...

Before smartphones, few people used software every day outside of those who were heavily invested in the tech space. Fast-forward to now, and more people use software and digital apps than ever before ...